(https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html) with robust pharma demand, and (https://www.cnbc.com/2026/08/05/cvs-health-cvs-earnings-q2-2026.html) on improving health services economics. But here's what the crowd missed: Lilly's net margin is 37.4% and YoY revenue growth stands at 301.1%, yet the company is guiding into a materially slower growth profile for the remainder of the year.

Research these companies